BSE filing, NSE: PURVA. Summary written from the filing by ALFA Finder's alert engine.
Puravankara Ltd: key numbers
- Share price
- ₹195.78
- Market cap
- ₹4,643 Cr
- Revenue (annual)
- ₹3,740 Cr
- Net profit (annual)
- ₹63.71 Cr
- P/E (TTM)
- 29.0×Sector 33.7×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 16.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Puravankara Ltd
All →Puravankara Merger & Restructuring Worth ₹0.01 Cr
Puravankara Limited has incorporated a wholly-owned subsidiary, Burgundyprime Realty Private Limited, by subscribing to 9,999 equity shares for Rs. 0.01 Crore.
- Value
- ₹0.01 Cr
Puravankara Business Update
Puravankara reported Q2FY27 pre-sales of ₹2,136 crore, up 62% YoY, with collections at ₹1,301 crore. The company added 10.74 msft pipeline worth ₹14,100 crore GDV in H1FY27.
- pipeline developable area added
- 10.74 msft
Puravankara Other Announcement
Puravankara Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Puravankara Capacity Expansion: ₹2,500 Cr Investment
Puravankara signed a JDA for a 12.76-acre Sathanur, Bengaluru parcel with an estimated GDV of ₹2,500 Crore. The 1.90 msft project expands its residential development pipeline.
- Value
- ₹2,500 Cr
- saleable area
- 1.9 msft
Puravankara Debt & Borrowing: ₹25 Cr
Puravankara Limited allotted 250 unlisted non-convertible debentures as the fourth and final tranche, raising ₹25 Crore via private placement.
- Value
- ₹25.00 Cr
Puravankara Debt & Borrowing
Puravankara Limited has allotted non-convertible debt securities. This filing confirms the completion of the issuance process.
Other board meeting date announcements
All →Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 13 November 2026 to consider unaudited quarterly results and an interim dividend. Trading window closed until 15 November 2026.
Faze Three Board Meeting Date
Faze Three Ltd intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closure is also noted.
Real Eco-Energy Board Meeting Date
Real Eco-Energy schedules a board meeting on 04 November 2026 for unaudited quarterly results. The trading window stays closed until results are declared.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare schedules a 4 November 2026 board meeting on rights issue, draft letter of offer and related party transactions. Agenda items remain proposed only.
Prism Johnson Board Meeting Date
Prism Johnson intimated a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting has not yet been held.
Bharat Textiles & Proofing Industries Board Meeting Date
Bharat Textiles & Proofing Industries will hold a board meeting on 05 November 2026 to consider unaudited standalone quarterly and half-year results. Results await approval.